← Back
$MAIA All transactions

MAIA Biotechnology, Inc.

▲ BUY
7 / 10

Conviction

$ Value

$15K

Shares

15,000

Price

$1

Filed

Nov 26

Why this score? (7/10)
  • Open market buy (+3)
  • Director (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Smith Stan

Title

CIK

0001913199

Roles

Director

Transaction Details

Transaction Date

2025-11-25

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,349,289

Footnotes

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. | These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. | The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Filing Info

Accession No.

0001878313-25-000045

Form Type

4

Issuer CIK

0001878313

Smith Stan's History

Date Ticker Type Value
2026-03-31 MAIA A $0
2025-12-31 MAIA A $0
2025-12-22 MAIA $70K
2025-12-22 MAIA $78K
2025-12-05 MAIA $5K
2025-12-05 MAIA $5K
2025-12-05 MAIA $5K
2025-11-26 MAIA $16K
2025-11-25 MAIA $15K
2025-11-24 MAIA $10K

Other Insiders at MAIA (90d)

Insider Bought Sold Last
CHAOUKI STEVEN M 2026-03-31
Smith Stan 2026-03-31
Gryaznov Sergei
Chief Scientific Officer
2026-04-10
Guerrero Ramiro 2026-03-31
Vitoc Vlad
Chief Executive Officer
2026-04-10
Louie Ngar Yee 2026-03-31
Luput Cristian 2026-03-31
Theagene Jean-Manasse 2026-03-31
Himmelreich Jeffrey C
Head of Finance
2026-04-10